LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -311.24%-1.06M | -8.45%-1.18M | 272.96%869K | 81.41%-647K | 126.40%467K | -49.13%-258K | -226.78%-1.09M | 109.72%233K | -411.83%-3.48M | -349.51%-1.77M |
Net income from continuing operations | -15.61%-837K | 85.11%-127K | 68.13%-442K | 52.39%-1.98M | 213.23%984K | 0.00%-724K | 22.31%-853K | 5.52%-1.39M | 44.38%-4.16M | 12.40%-869K |
Depreciation and amortization | 83.10%130K | 5.80%73K | 2.86%72K | -1.05%282K | -5.26%72K | 1.43%71K | -1.43%69K | 1.45%70K | 68.64%285K | 76.74%76K |
Other non cash items | ---- | ---- | ---- | ---206K | ---52K | ---152K | ---1K | ---1K | ---- | ---- |
Change In working capital | -474.75%-742K | -89.57%-1.2M | 3.49%889K | 81.33%-388K | 51.49%-812K | 181.82%198K | -144.33%-633K | 154.03%859K | -202.11%-2.08M | -232.75%-1.67M |
-Change in receivables | 99.04%-11K | -174.71%-573K | 316.00%1.94M | -357.79%-2.12M | -6,292.31%-831K | -577.06%-1.15M | 723.58%767K | -476.92%-900K | -541.67%-462K | -102.23%-13K |
-Change in payables and accrued expense | -157.19%-175K | -46.66%-965K | -145.08%-353K | 336.92%616K | -43.60%185K | 436.26%306K | -200.92%-658K | 168.15%783K | -116.76%-260K | -41.43%328K |
-Change in other current assets | -42.58%120K | 127.27%9K | 126.21%38K | -588.24%-166K | -38.73%-197K | 202.90%209K | -121.15%-33K | -195.92%-145K | 111.11%34K | -162.28%-142K |
-Change in other current liabilities | ---- | ---- | ---- | 97.56%-25K | ---25K | ---- | ---- | ---- | ---1.02M | ---- |
-Change in other working capital | -158.27%-486K | 146.40%329K | -166.01%-740K | 454.77%1.3M | 106.80%56K | 1,768.00%834K | -195.42%-709K | 575.00%1.12M | -142.58%-367K | -655.96%-824K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -311.24%-1.06M | -8.45%-1.18M | 272.96%869K | 81.41%-647K | 126.40%467K | -49.13%-258K | -226.78%-1.09M | 109.72%233K | -411.83%-3.48M | -349.51%-1.77M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -1,063.27%-472K | -5,600.00%-798K | 25,923.53%4.39M | 91.84%-414K | 91.20%-432K | 644.44%49K | 44.00%-14K | 87.02%-17K | -666.16%-5.07M | -1,419.20%-4.91M |
Net PPE purchase and sale | 24.32%-28K | 28.57%-10K | 47.06%-9K | 51.56%-93K | 7.41%-25K | -311.11%-37K | 44.00%-14K | 87.02%-17K | ---192K | ---27K |
Net intangibles purchase and sale | ---444K | ---788K | ---601K | ---407K | ---407K | --0 | --0 | --0 | --0 | ---- |
Net investment purchase and sale | --0 | --0 | --5M | 101.76%86K | --0 | --86K | --0 | --0 | ---4.88M | ---4.88M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -1,063.27%-472K | -5,600.00%-798K | 25,923.53%4.39M | 91.84%-414K | 91.20%-432K | 644.44%49K | 44.00%-14K | 87.02%-17K | -666.16%-5.07M | -1,419.20%-4.91M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 242.86%20K | 0 | 0 | -259.79%-155K | -117.53%-17K | -14K | -67K | -57K | 27.63%97K | 97K |
Net issuance payments of debt | ---- | ---- | ---- | -201.03%-98K | ---147K | ---- | ---- | ---- | 870.00%97K | ---- |
Net other financing activities | ---- | ---- | ---- | ---57K | --130K | ---63K | ---67K | ---57K | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 242.86%20K | --0 | --0 | -259.79%-155K | -117.53%-17K | ---14K | ---67K | ---57K | 27.63%97K | --97K |
Net cash flow | ||||||||||
Beginning cash position | 73.48%7.26M | 72.53%9.24M | -23.40%3.98M | -61.94%5.2M | -66.35%3.96M | -65.00%4.19M | -51.86%5.36M | -61.94%5.2M | 4.04%13.65M | -11.24%11.78M |
Current changes in cash | -578.48%-1.51M | -69.15%-1.98M | 3,207.55%5.26M | 85.62%-1.22M | 100.27%18K | -22.53%-223K | -240.29%-1.17M | 106.29%159K | -1,695.28%-8.46M | -1,808.83%-6.58M |
End cash Position | 45.05%5.75M | 73.48%7.26M | 72.53%9.24M | -23.40%3.98M | -23.40%3.98M | -66.35%3.96M | -65.00%4.19M | -51.86%5.36M | -61.94%5.2M | -61.94%5.2M |
Free cash flow | -419.66%-1.53M | -79.42%-1.98M | 19.91%259K | 68.76%-1.15M | 101.95%35K | -62.09%-295K | -232.25%-1.1M | 108.54%216K | -908.81%-3.67M | -565.28%-1.8M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |